Lara Rodriguez Sanchez, Samir Taneja, Hashim Ahmed, Himanshu Nagar, Edward Schaeffer in a Crossfire: Controversies in Urology debate: discussed if Focal Therapy is a Suitable Option for all Cases with ...

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Overall, 745 participants had a score in the 90th percentile or higher and were invited to undergo screening; 468 (62.8)% ...

and calculated their risk of developing prostate cancer. Article continues below Men in the top 10 per cent of scores were then invited for a biopsy and an MRI scan. Out of 745 men with a high ...

Of those, 745 (12%) were deemed to have a high risk score and were invited to have prostate cancer screening, including an MRI scan and a biopsy. Prostate cancer was detected in 187 of the 468 who ...

These men were invited to have prostate cancer screening including an MRI scan and a biopsy, with some 468 taking up the offer. Prostate cancer was detected in 187 men and, of these, 103 had ...

However, experts typically do not recommend them as a general cancer screening tool. A full-body MRI can detect chronic health conditions, including tumors, inflammation, bone problems, and blood ...

These men were invited to have prostate cancer screening including an MRI scan and a biopsy, with some 468 taking up the offer. Prostate cancer was detected in 187 men and, of these, 103 had ...

About 55,000 cases of prostate cancer are diagnosed each year in Britain, with 12,000 men dying. A separate trial has been launched that will compare the saliva tests to the PSA test and an MRI scan.

Researchers say the test is so effective it could 'turn the tide' on the disease and help identify at-risk men without the need for a GP appointment. They estimate it could find 12,350 tumours at ...

This is the trouble with prostate cancer screening and is why, despite pressure from charities, the National Screening Committee (NSC) and scientists are reluctant to add it to the list of routine ...

Of these 745 participants, 468 (62.8%) underwent MRI and prostate biopsy; prostate cancer was detected in 187 participants (40.0%). The median age at diagnosis was 64 years (range, 57 to 73).